A complex containing lpp and α-actinin mediates TGFβ-induced migration and invasion of ErbB2- expressing breast cancer cells

Journal of Cell Science

Volumn 126, Issue 9, 2013, Pages 1981-1991

  Ngan, Elaine ^a,b   Northey, Jason J ^a,b   Brown, Claire M ^b   Ursini Siegel, Josie ^c   Siegel, Peter M ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Breast cancer; EMT; ErbB2; Invasion; LPP; Migration; TGF

Indexed keywords

ALPHA ACTININ; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN LPP; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CELL; CANCER CELL; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; COMPLEX FORMATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FOCAL ADHESION; HUMAN; HUMAN CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BREAST CANCER; EMT; ERBB2; INVASION; LPP; MIGRATION; TGFΒ;

ACTININ; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CYTOSKELETAL PROTEINS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIM DOMAIN PROTEINS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; MULTIPROTEIN COMPLEXES; NEOPLASM INVASIVENESS; RECEPTOR, ERBB-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 84878653177     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.118315     Document Type: Article

References (80)

1. Alabert, C., Rogers, L., Kahn, L., Niellez, S., Fafet, P., Cerulis, S., Blanchard, J. M., Hipskind, R. A. and Vignais, M. L. (2006). Cell type-dependent control of NF-Y activity by TGF-beta. Oncogene 25, 3387-3396.
2. Ansieau, S., Bastid, J., Doreau, A., Morel, A. P., Bouchet, B. P., Thomas, C., Fauvet, F., Puisieux, I., Doglioni, C., Piccinin, S. et al. (2008). Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell 14, 79-89.
3. Barcellos-Hoff, M. H. and Akhurst, R. J. (2009). Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res. 11, 202.
4. Bargmann, C. I. and Weinberg, R. A. (1988). Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J. 7, 2043-2052.
5. Bhatt, A., Kaverina, I., Otey, C. and Huttenlocher, A. (2002). Regulation of focal complex composition and disassembly by the calcium-dependent protease calpain. J. Cell Sci. 115, 3415-3425.
6. Bierie, B. and Moses, H. L. (2009). Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle 8, 3319-3327.
7. Choi, C. K., Vicente-Manzanares, M., Zareno, J., Whitmore, L. A., Mogilner, A. and Horwitz, A. R. (2008). Actin and alpha-actinin orchestrate the assembly and maturation of nascent adhesions in a myosin II motor-independent manner. Nat. Cell Biol. 10, 1039-1050.
8. Chow, A., Arteaga, C. L. and Wang, S. E. (2011). When tumor suppressor TGFb meets the HER2 (ERBB2) oncogene. J. Mammary Gland Biol. Neoplasia 16, 81-88.
9. Christerson, L. B., Vanderbilt, C. A. and Cobb, M. H. (1999). MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions. Cell Motil. Cytoskeleton 43, 186-198.
10. Colas, E., Muinelo-Romay, L., Alonso-Alconada, L., Llaurado, M., Monge, M., Barbazan, J., Gonzalez, M., Schoumacher, M., Pedrola, N., Ertekin, T. et al. (2012). ETV5 cooperates with LPP as a sensor of extracellular signals and promotes EMT in endometrial carcinomas. Oncogene 31, 4778-4788.
11. Cuevas, B. D., Abell, A. N., Witowsky, J. A., Yujiri, T., Johnson, N. L., Kesavan, K., Ware, M., Jones, P. L., Weed, S. A., DeBiasi, R. L. et al. (2003). MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J. 22, 3346-3355.
12. Deckers, M., van Dinther, M., Buijs, J., Que, I., Löwik, C., van der Pluijm, G. and ten Dijke, P. (2006). The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209.
13. Derynck, R., Akhurst, R. J. and Balmain, A. (2001). TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet. 29, 117-129.
14. Franco, S. J. and Huttenlocher, A. (2005). Regulating cell migration: calpains make the cut. J. Cell Sci. 118, 3829-3838.
15. Galliher, A. J. and Schiemann, W. P. (2006). Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 8, R42.
16. Giampieri, S., Manning, C., Hooper, S., Jones, L., Hill, C. S. and Sahai, E. (2009). Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat. Cell Biol. 11, 1287-1296.
17. Gorenne, I., Nakamoto, R. K., Phelps, C. P., Beckerle, M. C., Somlyo, A. V. and Somlyo, A. P. (2003). LPP, a LIM protein highly expressed in smooth muscle. Am. J. Physiol. Cell Physiol. 285, C674-C685.
18. Gorenne, I., Jin, L., Yoshida, T., Sanders, J. M., Sarembock, I. J., Owens, G. K., Somlyo, A. P. and Somlyo, A. V. (2006). LPP expression during in vitro smooth muscle differentiation and stent-induced vascular injury. Circ. Res. 98, 378-385.
19. Grashoff, C., Hoffman, B. D., Brenner, M. D., Zhou, R., Parsons, M., Yang, M. T., McLean, M. A., Sligar, S. G., Chen, C. S., Ha, T. et al. (2010). Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature 466, 263-266.
20. Grunewald, T. G., Pasedag, S. M. and Butt, E. (2009). Cell adhesion and transcriptional activity-defining the role of the novel protooncogene LPP. Transl. Oncol. 2, 107-116.
21. Guo, B., Sallis, R. E., Greenall, A., Petit, M. M., Jansen, E., Young, L., Van de Ven, W. J. and Sharrocks, A. D. (2006). The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3. Mol. Cell. Biol. 26, 4529-4538.
22. Hampton, C. M., Taylor, D. W. and Taylor, K. A. (2007). Novel structures for alphaactinin: F-actin interactions and their implications for actin-membrane attachment and tension sensing in the cytoskeleton. J. Mol. Biol. 368, 92-104.
23. Hansen, M. D. and Beckerle, M. C. (2008). alpha-Actinin links LPP, but not zyxin, to cadherin-based junctions. Biochem. Biophys. Res. Commun. 371, 144-148.
24. Hardy, K. M., Booth, B. W., Hendrix, M. J., Salomon, D. S. and Strizzi, L. (2010). ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 15, 191-199.
25. Hirata, H., Tatsumi, H. and Sokabe, M. (2008). Zyxin emerges as a key player in the mechanotransduction at cell adhesive structures. Commun. Integr. Biol. 1, 192-195.
26. Hirota, T., Morisaki, T., Nishiyama, Y., Marumoto, T., Tada, K., Hara, T., Masuko, N., Inagaki, M., Hatakeyama, K. and Saya, H. (2000). Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J. Cell Biol. 149, 1073-1086.
27. Jin, L., Kern, M. J., Otey, C. A., Wamhoff, B. R. and Somlyo, A. V. (2007). Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ. Res. 100, 817-825.
28. Kang, Y., He, W., Tulley, S., Gupta, G. P., Serganova, I., Chen, C. R., Manova-Todorova, K., Blasberg, R., Gerald, W. L. and Massagué, J. (2005). Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102, 13909-13914.
29. Keicher, C., Gambaryan, S., Schulze, E., Marcus, K., Meyer, H. E. and Butt, E. (2004). Phosphorylation of mouse LASP-1 on threonine 156 by cAMP-and cGMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 324, 308-316.
30. Lele, T. P., Pendse, J., Kumar, S., Salanga, M., Karavitis, J. and Ingber, D. E. (2006). Mechanical forces alter zyxin unbinding kinetics within focal adhesions of living cells. J. Cell. Physiol. 207, 187-194.
31. Li, B., Zhuang, L., Reinhard, M. and Trueb, B. (2003). The lipoma preferred partner LPP interacts with alpha-actinin. J. Cell Sci. 116, 1359-1366.
32. Liu, S., Xu, S. W., Kennedy, L., Pala, D., Chen, Y., Eastwood, M., Carter, D. E., Black, C. M., Abraham, D. J. and Leask, A. (2007). FAK is required for TGFbetainduced JNK phosphorylation in fibroblasts: implications for acquisition of a matrixremodeling phenotype. Mol. Biol. Cell 18, 2169-2178.
33. Majesky, M. W. (2006). Organizing motility: LIM domains, LPP, and smooth muscle migration. Circ. Res. 98, 306-308.
34. Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M. et al. (2008). The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715.
35. Mourskaia, A. A., Dong, Z., Ng, S., Banville, M., Zwaagstra, J. C., O'Connor-McCourt, M. D. and Siegel, P. M. (2009). Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Oncogene 28, 1005-1015.
36. Moustakas, A. and Heldin, C. H. (2007). Signaling networks guiding epithelialmesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 98, 1512-1520.
37. Muraoka, R. S., Dumont, N., Ritter, C. A., Dugger, T. C., Brantley, D. M., Chen, J., Easterly, E., Roebuck, L. R., Ryan, S., Gotwals, P. J. et al. (2002). Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109, 1551-1559.
38. Muraoka, R. S., Koh, Y., Roebuck, L. R., Sanders, M. E., Brantley-Sieders, D., Gorska, A. E., Moses, H. L. and Arteaga, C. L. (2003). Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol. Cell. Biol. 23, 8691-8703.
39. Muraoka-Cook, R. S., Kurokawa, H., Koh, Y., Forbes, J. T., Roebuck, L. R., Barcellos-Hoff, M. H., Moody, S. E., Chodosh, L. A. and Arteaga, C. L. (2004). Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 64, 9002-9011.
40. Northey, J. J., Chmielecki, J., Ngan, E., Russo, C., Annis, M. G., Muller, W. J. and Siegel, P. M. (2008). Signaling through ShcA is required for TGF-{beta} and Neu/ ErbB-2 induced breast cancer cell motility and invasion. Mol. Cell. Biol. 28, 3162-3176.
41. Oakes, P. W., Beckham, Y., Stricker, J. and Gardel, M. L. (2012). Tension is required but not sufficient for focal adhesion maturation without a stress fiber template. J. Cell Biol. 196, 363-374.
42. Otey, C. A. and Carpen, O. (2004). Alpha-actinin revisited: a fresh look at an old player. Cell Motil. Cytoskeleton 58, 104-111.
43. Ozdamar, B., Bose, R., Barrios-Rodiles, M., Wang, H. R., Zhang, Y. and Wrana, J. L. (2005). Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307, 1603-1609.
44. Padua, D. and Massagué, J. (2009). Roles of TGFbeta in metastasis. Cell Res. 19, 89-102.
45. Padua, D., Zhang, X. H., Wang, Q., Nadal, C., Gerald, W. L., Gomis, R. R. and Massagué, J. (2008). TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 133, 66-77.
46. Petit, M. M., Fradelizi, J., Golsteyn, R. M., Ayoubi, T. A., Menichi, B., Louvard, D., Van de Ven, W. J. and Friederich, E. (2000). LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity. Mol. Biol. Cell 11, 117-129.
47. Petit, M. M., Meulemans, S. M. and Van de Ven, W. J. (2003). The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein. J. Biol. Chem. 278, 2157-2168.
48. Petit, M. M., Meulemans, S. M., Alen, P., Ayoubi, T. A., Jansen, E. and Van de Ven, W. J. (2005). The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus. BMC Cell Biol. 6, 1.
49. Pierceall, W. E., Woodard, A. S., Morrow, J. S., Rimm, D. and Fearon, E. R. (1995). Frequent alterations in E-cadherin and alpha-and beta-catenin expression in human breast cancer cell lines. Oncogene 11, 1319-1326.
50. Pratt, S. J., Epple, H., Ward, M., Feng, Y., Braga, V. M. and Longmore, G. D. (2005). The LIM protein Ajuba influences p130Cas localization and Rac1 activity during cell migration. J. Cell Biol. 168, 813-824.
51. Rahimi, R. A. and Leof, E. B. (2007). TGF-beta signaling: a tale of two responses. J. Cell. Biochem. 102, 593-608.
52. Safina, A., Ren, M. Q., Vandette, E. and Bakin, A. V. (2008). TAK1 is required for TGF-beta 1-mediated regulation of matrix metalloproteinase-9 and metastasis. Oncogene 27, 1198-1207.
53. Safina, A. F., Varga, A. E., Bianchi, A., Zheng, Q., Kunnev, D., Liang, P. and Bakin, A. V. (2009). Ras alters epithelial-mesenchymal transition in response to TGFbeta by reducing actin fibers and cell-matrix adhesion. Cell Cycle 8, 284-298.
54. Safina, A., Sotomayor, P., Limoge, M., Morrison, C. and Bakin, A. V. (2011). TAK1-TAB2 signaling contributes to bone destruction by breast carcinoma cells. Mol. Can. Res. 9, 1042-1053.
55. Sen, S., Dong, M. and Kumar, S. (2009). Isoform-specific contributions of alphaactinin to glioma cell mechanobiology. PLoS ONE 4, e8427.
56. Seton-Rogers, S. E., Lu, Y., Hines, L. M., Koundinya, M., LaBaer, J., Muthuswamy, S. K. and Brugge, J. S. (2004). Cooperation of the ErbB2 receptor and transforming growth factor beta in induction of migration and invasion in mammary epithelial cells. Proc. Natl. Acad. Sci. USA 101, 1257-1262.
57. Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J. and Massagué, J. (2003). Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100, 8430-8435.
58. Sjöblom, B., Salmazo, A. and Djinović-Carugo, K. (2008). Alpha-actinin structure and regulation. Cell. Mol. Life Sci. 65, 2688-2701.
59. Thiery, J. P., Acloque, H., Huang, R. Y. and Nieto, M. A. (2009). Epithelialmesenchymal transitions in development and disease. Cell 139, 871-890.
60. Tomaskovic-Crook, E., Thompson, E. W. and Thiery, J. P. (2009). Epithelial to mesenchymal transition and breast cancer. Breast Can. Res. 11, 213.
61. Ueda, Y., Wang, S., Dumont, N., Yi, J. Y., Koh, Y. and Arteaga, C. L. (2004). Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. J. Biol. Chem. 279, 24505-24513.
62. Uemura, A., Nguyen, T. N., Steele, A. N. and Yamada, S. (2011). The LIM domain of zyxin is sufficient for force-induced accumulation of zyxin during cell migration. Biophys. J. 101, 1069-1075.
63. Ursini-Siegel, J., Hardy, W. R., Zuo, D., Lam, S. H. L., Sanguin-Gendreau, V., Cardiff, R. D., Pawson, T. and Muller, W. J. (2008). ShcA signalling is essential for tumour progression in mouse models of human breast cancer. EMBO 27, 910-920.
64. Vervenne, H. B., Crombez, K. R., Lambaerts, K., Carvalho, L., Köppen, M., Heisenberg, C. P., Van de Ven, W. J. and Petit, M. M. (2008). Lpp is involved in Wnt/PCP signaling and acts together with Scrib to mediate convergence and extension movements during zebrafish gastrulation. Dev. Biol. 320, 267-277.
65. Vervenne, H. B., Crombez, K. R., Delvaux, E. L., Janssens, V., Van de Ven, W. J. and Petit, M. M. (2009). Targeted disruption of the mouse Lipoma Preferred Partner gene. Biochem. Biophys. Res. Commun. 379, 368-373.
66. Vicente-Manzanares, M., Choi, C. K. and Horwitz, A. R. (2009). Integrins in cell migration-the actin connection. J. Cell Sci. 122, 199-206.
67. Viloria-Petit, A. M., David, L., Jia, J. Y., Erdemir, T., Bane, A. L., Pinnaduwage, D., Roncari, L., Narimatsu, M., Bose, R., Moffat, J. et al. (2009). A role for the TGFbeta-Par6 polarity pathway in breast cancer progression. Proc. Natl. Acad. Sci. USA 106, 14028-14033.
68. Wang, S. E., Shin, I., Wu, F. Y., Friedman, D. B. and Arteaga, C. L. (2006). HER2/ Neu (ErbB2) signaling to Rac1-Pak1 is temporally and spatially modulated by transforming growth factor beta. Cancer Res. 66, 9591-9600.
69. Wang, S. E., Xiang, B., Guix, M., Olivares, M. G., Parker, J., Chung, C. H., Pandiella, A. and Arteaga, C. L. (2008). Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab. Mol. Cell. Biol. 28, 5605-5620.
70. Wang, S. E., Xiang, B., Zent, R., Quaranta, V., Pozzi, A. and Arteaga, C. L. (2009). Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res. 69, 475-482.
71. Wendt, M. K., Smith, J. A. and Schiemann, W. P. (2010). Transforming growth factor-b-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29, 6485-6498.
72. Wiercinska, E., Naber, H. P., Pardali, E., van der Pluijm, G., van Dam, H. and ten Dijke, P. (2011). The TGF-b/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res. Treat. 128, 657-666.
73. Wilkes, M. C. and Leof, E. B. (2006). Transforming growth factor beta activation of c-Abl is independent of receptor internalization and regulated by phosphatidylinositol 3-kinase and PAK2 in mesenchymal cultures. J. Biol. Chem. 281, 27846-27854.
74. Willier, S., Butt, E., Richter, G. H., Burdach, S. and Grunewald, T. G. (2011). Defining the role of TRIP6 in cell physiology and cancer. Biol. Cell 103, 573-591.
75. Wolfenson, H., Bershadsky, A., Henis, Y. I. and Geiger, B. (2011). Actomyosingenerated tension controls the molecular kinetics of focal adhesions. J. Cell Sci. 124, 1425-1432.
76. Xu, J., Lamouille, S. and Derynck, R. (2009). TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172.
77. Yi, J. and Beckerle, M. C. (1998). The human TRIP6 gene encodes a LIM domain protein and maps to chromosome 7q22, a region associated with tumorigenesis. Genomics 49, 314-316.
78. Yin, J. J., Selander, K., Chirgwin, J. M., Dallas, M., Grubbs, B. G., Wieser, R., Massagué, J., Mundy, G. R. and Guise, T. A. (1999). TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103, 197-206.
79. Zhang, L., Wang, W., Hayashi, Y., Jester, J. V., Birk, D. E., Gao, M., Liu, C. Y., Kao, W. W., Karin, M. and Xia, Y. (2003). A role for MEK kinase 1 in TGF-beta/ activin-induced epithelium movement and embryonic eyelid closure. EMBO J. 22, 4443-4454.
80. Zhang, H., Chen, X., Bollag, W. B., Bollag, R. J., Sheehan, D. J. and Chew, C. S. (2009). Lasp1 gene disruption is linked to enhanced cell migration and tumor formation. Physiol. Genomics 38, 372-385.